secwatch.observer — SEC 8-K summary
======================================

Issuer:     VSEE HEALTH, INC. (VSEE)
CIK:        0001864531
Form:       8-K
Filed at:   2026-06-05T20:15:29+00:00
Accession:  0001185185-26-002359
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VSee Health sells VSee Lab to co-CEO Chen; Chen resigns, Aisiku becomes sole CEO and Chairman
--------------------------------------------------------------------------------

- VSee Health sold all equity of VSee Lab to Milton Chen in exchange for Chen's 2,870,069 shares of VSEE common stock, effectively retiring those shares.
- Chen resigned as co-CEO and Chairman effective May 31, 2026; Dr. Imoigele Aisiku appointed as sole CEO and Chairman.
- Pro forma net loss improves: Q1 2026 from $2.6M to $1.26M; FY2025 from $14.7M to $10.0M, driven by elimination of VSee Lab's operations.
- VSee Lab contributed $1.28M in Q1 2026 revenue and $7.3M in FY2025 revenue; all revenues and costs removed from ongoing results.
- Transaction is a related-party exchange; company retains pre-closing liabilities of VSee Lab; Chen assumes post-closing liabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/vsee8k060526.htm
  HTML page:      https://secwatch.observer/filing/0001185185-26-002359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer